Application of Genomic Technologies to Human Prostate Cancer

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Omics

• Publication date

  2006-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/omi.2006.10.261PMID 17069507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

  2006cited by this paper
• Proteome analysis of prostate cancer

  2005cited by this paper
• Application of protein lysate microarrays to molecular marker verification and quantification

  2005cited by this paper
• Mass Spectrometry-based Expression Profiling of Clinical Prostate Cancer

  2005cited by this paper
• Prostate cancer and the genomic revolution: Advances using microarray analyses.

  2005cited by this paper
• Proteomics in prostate cancer

  2005cited by this paper
• Gene Expression Profiling Predicts Survival in Conventional Renal Cell Carcinoma

  2005cited by this paper
• Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors

  2005cited by this paper
• Genome‐wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines

  2005cited by this paper
• Autoantibody signatures in prostate cancer.

  2005cited by this paper
• Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer.

  2005cited by this paper
• Primary cell cultures as models of prostate cancer development.

  2005cited by this paper
• Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors.

  2005cited by this paper
• Molecular pathology of prostate cancer: the key to identifying new biomarkers of disease.

  2004cited by this paper
• Clinical proteomics: Applications for prostate cancer biomarker discovery and detection.

  2004cited by this paper
• Gene expression profiling identifies clinically relevant subtypes of prostate cancer.

  2004influential reference
• Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds

  2004cited by this paper
• Gene expression profiling predicts clinical outcome of prostate cancer.

  2004cited by this paper
• Molecular Features of the Transition from Prostatic Intraepithelial Neoplasia (PIN) to Prostate Cancer

  2004cited by this paper
• Gene Duplication: The Genomic Trade in Spare Parts

  2004cited by this paper
• In silico dissection of cell-type-associated patterns of gene expression in prostate cancer.

  2004cited by this paper
• Quantitative Proteomic Analysis of Proteins Released by Neoplastic Prostate Epithelium

  2004cited by this paper
• Determinants of long‐term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer

  2004cited by this paper
• Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

  2004cited by this paper
• Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

  2004cited by this paper
• Androgen-Induced Differentiation and Tumorigenicity of Human Prostate Epithelial Cells

  2004cited by this paper
• Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors

  2004cited by this paper
• Ets proteins in biological control and cancer

  2004cited by this paper
• High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression.

  2004influential reference
• The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis

  2003cited by this paper
• Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP.

  2003cited by this paper
• Molecular biology of the Ets family of transcription factors.

  2003cited by this paper
• Comparative analysis of amplified and nonamplified RNA for hybridization in cDNA microarray.

  2003cited by this paper
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.

  2003cited by this paper
• Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays

  2003cited by this paper
• Genetic markers useful for distinguishing between organ‐confined and locally advanced prostate cancer

  2003cited by this paper
• Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.

  2003cited by this paper
• Molecular characterization of human prostate carcinoma cell lines

  2003cited by this paper
• Genetic profiling of Gleason grade 4/5 prostate cancer: which is the best prostatic control tissue?

  2003cited by this paper
• Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue.

  2002cited by this paper
• Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer.

  2002cited by this paper
• Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

  2002cited by this paper
• Advantages of mRNA amplification for microarray analysis.

  2002cited by this paper
• Within the fold: assessing differential expression measures and reproducibility in microarray assays

  2002cited by this paper
• The polycomb group protein EZH2 is involved in progression of prostate cancer

  2002cited by this paper
• α-methylacyl-CoA racemase: A new molecular marker for prostate cancer

  2002cited by this paper
• Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancer †

  2002cited by this paper
• Gene expression correlates of clinical prostate cancer behavior.

  2002influential reference
• Transcript map of the 8p23 putative tumor suppressor region.

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer.

  2001cited by this paper
• Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.

  2001influential reference
• Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.

  2001cited by this paper
• Diversity of gene expression in adenocarcinoma of the lung

  2001cited by this paper
• Delineation of prognostic biomarkers in prostate cancer

  2001influential reference
• Expression profiling reveals hepsin overexpression in prostate cancer.

  2001cited by this paper
• Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

  2001cited by this paper
• Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation

  2000cited by this paper
• Diagnosis of localized prostate cancer: 10 years of progress

  2000cited by this paper
• PART-1: a novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12.

  2000cited by this paper
• 8pter-p23 deletion is associated with racial differences in prostate cancer outcome.

  2000cited by this paper
• Prostatic intraepithelial neoplasia

  2000cited by this paper
• High-fidelity mRNA amplification for gene profiling

  2000cited by this paper
• STAT3 mediates IL‐6‐induced growth inhibition in the human prostate cancer cell line LNCaP

  2000cited by this paper
• Genome-wide analysis of DNA copy-number changes using cDNA microarrays

  1999cited by this paper
• Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays

  1999cited by this paper
• Laser-capture microdissection: opening the microscopic frontier to molecular analysis.

  1998cited by this paper
• HISTOLOGICAL GRADE HETEROGENEITY IN MULTIFOCAL PROSTATE CANCER. BIOLOGICAL AND CLINICAL IMPLICATIONS

  1996cited by this paper
• Laser Capture Microdissection

  1996cited by this paper

• Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer

  2021cites this paper
• A modern era of personalized medicine in the diagnosis, prognosis, and treatment of prostate cancer

  2020cites this paper
• MP28-15 PREOPERATIVE KIDNEY FUNCTION TRENDS: IMPROVING ESTIMATES OF BASELINE KIDNEY FUNCTION PRIOR TO KIDNEY CANCER SURGERY

  2018cites this paper
• INTRA‐TUMOR HETEROGENEITY IN RENAL CELL CARCINOMA: IMPLICATIONS FOR PROTEOMIC ANALYSIS OF RENAL MASS BIOPSIES: MP39‐10

  2017cites this paper
• Multi-gene biomarker panel for reference free prostate cancer diagnosis: determination and independent validation

  2010cites this paper